Natural Product (NP) Details
General Information of the NP (ID: NP0754) | |||||
---|---|---|---|---|---|
Name |
Cordycepin
|
||||
Synonyms |
3'-deoxyadenosine
Click to Show/Hide
|
||||
Species Origin | Prunus persica ... | Click to Show/Hide | |||
Prunus persica | |||||
Allium cepa | |||||
Cordyceps militaris | |||||
Disease | Hepatocellular carcinoma [ICD-11: 2C12] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C10H13N5O3
|
||||
PubChem CID | |||||
Canonical SMILES |
C1C(OC(C1O)N2C=NC3=C(N=CN=C32)N)CO
|
||||
InChI |
1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,10+/m0/s1
|
||||
InChIKey |
OFEZSBMBBKLLBJ-BAJZRUMYSA-N
|
||||
CAS Number |
CAS 73-03-0
|
||||
Herb ID | |||||
SymMap ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Apatinib | Breast cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | PIK3CB | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | VEGFA | Molecule Info |
Pathway MAP
|
||
In-vitro Model | A-549 | CVCL_0023 | Lung adenocarcinoma | Homo sapiens | ||
PC-9 | CVCL_B260 | Lung adenocarcinoma | Homo sapiens | |||
Experimental
Result(s) |
Combination of cordycepin and apatinib synergistically inhibits NSCLC cells by down-regulating VEGF/PI3K/Akt signaling pathway. |